Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2021-11-08 00:00:00 ET · period of report 2021-10-27 · accession 0001104659-21-135706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-08 | 2021-10-27 | MBIO | Litchman Manuel MD | Pres, CEO, Dir | P - Purchase | $2.24 | +65.0K | 1.03M | +7% | +$145.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2021-10-27 | P | A | 65,000 | $2.24 | 1,027,987 | D | — | — | (F1) Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the purchase transactions on October 27, 2021, was $2.22 to $2.26. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares purchased at each separate price. (F2) Includes restricted stock units, which vest over various time periods. |